Refex Industries [REFEX] vs Soni Medicare [SML] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Refex Industries Ltd wins in 11 metrics, Soni Medicare Ltd. wins in 7 metrics, with 0 ties. Refex Industries Ltd appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Refex Industries Ltd Soni Medicare Ltd. Better
P/E Ratio (TTM) 19.53 115.75 Refex Industries Ltd
Price-to-Book Ratio 2.66 340.87 Refex Industries Ltd
Debt-to-Equity Ratio 13.65 12,636.41 Refex Industries Ltd
PEG Ratio 0.38 0.16 Soni Medicare Ltd.
EV/EBITDA 13.15 -47.04 Refex Industries Ltd
Profit Margin (TTM) 7.50% -7.45% Refex Industries Ltd
Operating Margin (TTM) 14.71% -13.97% Refex Industries Ltd
EBITDA Margin (TTM) 14.71% N/A N/A
Return on Equity 13.10% -14.35% Refex Industries Ltd
Return on Assets (TTM) 8.82% -0.84% Refex Industries Ltd
Free Cash Flow (TTM) $-4.85B $8.11M Soni Medicare Ltd.
Dividend Yield 0.13% N/A N/A
1-Year Return -34.42% 46.00% Soni Medicare Ltd.
Price-to-Sales Ratio (TTM) 1.61 1.12 Soni Medicare Ltd.
Enterprise Value $32.68B $396.03M Refex Industries Ltd
EV/Revenue Ratio 1.52 1.48 Soni Medicare Ltd.
Gross Profit Margin (TTM) 19.08% 73.93% Soni Medicare Ltd.
Revenue per Share (TTM) $164 $63 Refex Industries Ltd
Earnings per Share (Diluted) $12.91 $-4.68 Refex Industries Ltd
Beta (Stock Volatility) 1.67 -0.70 Soni Medicare Ltd.

Refex Industries Ltd vs Soni Medicare Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Refex Industries Ltd1.00%5.30%13.07%62.28%4.91%20.11%
Soni Medicare Ltd.0.00%0.00%0.00%18.80%-27.51%-27.51%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Refex Industries Ltd-34.42%183.11%1,007.94%12,858.33%4,655.35%4,562.67%
Soni Medicare Ltd.46.00%298.69%164.49%128.13%355.97%355.97%

Performance & Financial Health Analysis: Refex Industries Ltd vs Soni Medicare Ltd.

MetricREFEXSML
Market Information
Market Cap i₹34.58B₹299.48M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i689,43512
90 Day Avg. Volume i767,860158
Last Close₹314.10₹73.00
52 Week Range₹188.00 - ₹482.25₹43.82 - ₹114.15
% from 52W High-34.87%-36.05%
All-Time High₹600.00 (Sep 30, 2024)₹114.15 (Oct 30, 2025)
% from All-Time High-47.65%-36.05%
Growth Metrics
Quarterly Revenue Growth-0.20%-0.27%
Quarterly Earnings Growth0.08%-0.29%
Financial Health
Profit Margin (TTM) i0.08%-0.07%
Operating Margin (TTM) i0.15%-0.14%
Return on Equity (TTM) i0.13%-0.14%
Debt to Equity (MRQ) i13.6512,636.41
Cash & Liquidity
Book Value per Share (MRQ)₹94.84₹0.21
Cash per Share (MRQ)₹27.13₹3.47
Operating Cash Flow (TTM) i₹-3,255,464,000₹-10,735,087
Levered Free Cash Flow (TTM) i₹1.59B₹-1,863,768
Dividends
Last 12-Month Dividend Yield i0.13%N/A
Last 12-Month Dividend i₹0.50N/A

Valuation & Enterprise Metrics Analysis: Refex Industries Ltd vs Soni Medicare Ltd.

MetricREFEX (Apr 24, 2026)SML (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.53115.75
Forward P/E iN/AN/A
PEG Ratio i0.380.16
Price to Sales (TTM) i1.611.12
Price to Book (MRQ) i2.66340.87
Market Capitalization
Market Capitalization i₹34.58B₹299.48M
Enterprise Value i₹32.68B₹396.03M
Enterprise Value Metrics
Enterprise to Revenue i1.521.48
Enterprise to EBITDA i13.15-47.04
Risk & Other Metrics
Beta i1.67-0.70
Book Value per Share (MRQ) i₹94.84₹0.21

Financial Statements Comparison: Refex Industries Ltd vs Soni Medicare Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREFEX (2025)SML (2025)
Revenue/Sales i24.60B298.38M
Cost of Goods Sold i21.81B84.88M
COGS % of Revenue i88.6%28.4%
Gross Profit i2.80B213.51M
Gross Margin i11.4%71.6%
Research & Development iN/AN/A
Operating Income (EBIT) i1.79B11.34M
Operating Margin i7.3%3.8%
EBITDA i2.14B19.65M
EBITDA Margin i8.7%6.6%
Pre-Tax Income i2.00B-2.22M
Pre-Tax Income % of Revenue i8.1%-0.7%
Income Tax i415.30M-353,039
Income Tax % of Revenue i1.7%-0.1%
Net Income (Profit) i1.58B-1.86M
Profit Margin i6.4%-0.6%

Balance Sheet & Liquidity Metrics

MetricREFEX (2025)SML (2025)
Cash & Equivalents i2.81B20.10M
Total Current Assets i13.81B137.75M
Total Current Assets % of Revenue i56.2%46.2%
Total Current Liabilities i3.96B99.90M
Total Current Liabilities % of Revenue i16.1%33.5%
Long-Term Debt i1.88B94.12M
Long-Term Debt % of Revenue i7.7%31.5%
Total Shareholders Equity i12.12B12.98M
Retained Earnings i4.79B-29.75M
Retained Earnings % of Revenue i19.5%-10.0%
Property, Plant & Equipment i26.16M96.87M

Cash Flow Statement Comparison

MetricREFEX (2025)SML (2025)
Operating Cash Flow i-3.26B-10.74M
Operating Cash Flow % of Revenue i-13.2%-3.6%
Capital Expenditures i-2.21B-6.60M
Free Cash Flow i-4.85B8.11M
FCF Margin i-19.7%2.7%
Debt Repayment iN/A0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREFEXSML
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i137.20M4.26M
Float Shares i57.82M735,707
% Held by Insiders i56.78%81.66%
% Held by Institutions i0.47%0.00%
% Held by Public i42.75%18.34%

Dividend Analysis & Yield Comparison: Refex Industries Ltd vs Soni Medicare Ltd.

MetricREFEXSML
Last 12-Month Dividend i₹0.50N/A
Last 12-Month Dividend Yield i0.13%N/A
3-Year Avg Annual Dividend i₹0.20N/A
3-Year Avg Dividend Yield i0.07%N/A
3-Year Total Dividends i₹0.60N/A
Ex-Dividend DateAug 19, 2025N/A